Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Lilly to Participate in UBS Global Healthcare Conference 2022
02:00pm, Monday, 16'th May 2022
INDIANAPOLIS , May 16, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 24, 2022. Michael Mason, senior vice president, preside
Why Eli Lilly Shares Are Trading Higher Today
10:04am, Monday, 16'th May 2022
The FDA approved Eli Lilly And Co's (NYSE: LLY) injected drug tirzepatide, which has the brand name Mounjaro (tirzepatide), to help improve blood sugar control in adults with type 2 diabetes. The a
Mizuho: Lilly's newly approved diabetes drug expected to bring in $14 billion in sales by 2030
09:12am, Monday, 16'th May 2022
The Food and Drug Administration on Friday approved Eli Lilly & Co.'s LLY, +0.28% Mounjaro, a once-weekly injection for adults with type 2 diabetes. Patients enrolled in the Phase 3 clinical trial rep
The Most Exciting Market for Lilly's Diabetes Drug May Be Something Else
12:20pm, Saturday, 14'th May 2022
The Food and Drug Administration approved a new diabetes treatment from Eli Lilly on Friday.
Got $10,000? These 3 Growth Stocks Also Pay Dividends
10:53am, Thursday, 12'th May 2022
These stocks can make the most of your money.
Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID
09:47am, Thursday, 12'th May 2022
The FDA grants full approval to Lilly (LLY) and Incyte for COVID-19 in certain hospitalized adults. Olumiant is already authorized for emergency use for this indication since November 2020.
FDA approves Eli Lilly and Incyte's Olumiant for treatment of certain hospitalized adults with COVID-19
07:04am, Wednesday, 11'th May 2022
Eli Lilly & Co. LLY, -1.22% and Incyte INCY, +4.80% said Wednesday the Food and Drug Administration has approved the use of their Olumiant for the treatment of certain adults who are hospitalized with
Here's My Top Pharma Stock to Buy in May
10:15am, Friday, 06'th May 2022
This company has been flying high over the past 12 months.
Morgan Stanley issues its list of the 45 highest conviction stock picks; Here's our top 3
05:47am, Wednesday, 04'th May 2022
On April 29, American investment bank and financial services company, Morgan Stanley (NYSE: MS) issued a list of top analyst.
Called to Account: Drug companies are making an accounting change after the SEC cracked down on Biogen
03:04pm, Tuesday, 03'rd May 2022
Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront payments made to finance research and development at companies in w
Eli Lilly And Company (LLY) Signs $670 Million Deal With Genesis Therapeutics
02:48pm, Tuesday, 03'rd May 2022
Genesis Therapeutics and Eli Lilly And Company (NYSE: LLY) have signed a $670 million deal. These are the details.
Jim Cramer breaks down shares of Estee Lauder, Clorox, Eli Lilly and more
11:30am, Tuesday, 03'rd May 2022
'Mad Money' host Jim Cramer and the 'Squawk on the Street' team discuss shares of Estee Lauder, Chegg, Clorox, HCA Holdings and more following the opening bell on Tuesday.
Analyst Says Eli Lilly Is One of the Strongest Pharma Expansion Stories
05:08pm, Monday, 02'nd May 2022
To use a baseball analogy, Eli Lilly and Co. ( LLY , Financial) hit it out of the park in the first quarter. The Indianapolis-based Big Pharma company put big numbers on the scoreboard in the first th
Top Pharmaceutical Stocks To Watch In May 2022
09:45am, Saturday, 30'th Apr 2022
Check out these pharmaceutical stocks in the stock market today.
Biopharma can perform well in recession based on past data, says Wells Fargo's Mohit Bansal
03:22pm, Friday, 29'th Apr 2022
Mohit Bansal, Wells Fargo Securities senior equity analyst, joins 'Power Lunch' to discuss biopharma and the market.
